As a result, there was a significant association between high levels of SPRR2A and lymph node metastasis and TNM stage, but there was no significant association between SPRR2A expression and other clinicopathological characteristics. Here, SPRR2A is linked to metastatic malignant neoplasm in the lymph nodes.